ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Health & Wellness
The Food and Drug Administration has approved a new nasal spray for the treatment of severe depression.
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Vince" data-source="post: 140882" data-attributes="member: 843"><p>The Food and Drug Administration has approved a new nasal spray for the treatment of severe depression.</p><p>On Tuesday, the government agency announced Spravato nasal spray, also known as esketamine, can now be used "for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them."</p><p>"There has been a long-standing need for additional effective treatments for treatment-resistant depression, a serious and life-threatening condition," said Dr. Tiffany Farchione, acting director of the Division of Psychiatry Products in the FDA's Center for Drug Evaluation and Research,<a href="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm632761.htm" target="_blank"> in a statement</a>.</p><p>The FDA said patients with major depressive disorder who have tried at least two antidepressants are considered to have treatment-resistant depression.</p><p>It is estimated that approximately one-third of U.S. adults with a major depressive disorder have treatment-resistant depression, according to Janssen Pharmaceutical Companies of Johnson & Johnson, which developed Spravato.</p><p></p><p><a href="https://www.usatoday.com/story/money/2019/03/05/spravato-nasal-spray-esketamine-approved-fda-treat-depression/3073771002/" target="_blank">FDA approved nasal spray, known as esketamine, to treat major depression is biggest advance in years</a></p></blockquote><p></p>
[QUOTE="Vince, post: 140882, member: 843"] The Food and Drug Administration has approved a new nasal spray for the treatment of severe depression. On Tuesday, the government agency announced Spravato nasal spray, also known as esketamine, can now be used "for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them." "There has been a long-standing need for additional effective treatments for treatment-resistant depression, a serious and life-threatening condition," said Dr. Tiffany Farchione, acting director of the Division of Psychiatry Products in the FDA's Center for Drug Evaluation and Research,[URL='https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm632761.htm'] in a statement[/URL]. The FDA said patients with major depressive disorder who have tried at least two antidepressants are considered to have treatment-resistant depression. It is estimated that approximately one-third of U.S. adults with a major depressive disorder have treatment-resistant depression, according to Janssen Pharmaceutical Companies of Johnson & Johnson, which developed Spravato. [URL="https://www.usatoday.com/story/money/2019/03/05/spravato-nasal-spray-esketamine-approved-fda-treat-depression/3073771002/"]FDA approved nasal spray, known as esketamine, to treat major depression is biggest advance in years[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Health & Wellness
The Food and Drug Administration has approved a new nasal spray for the treatment of severe depression.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top